Skip to content

APOTHEEK MOENS MORTSEL

Active Public limited companyfounded 1997active for 28 yearsAntwerpsestraat 7, 2640 MortselKBO/BCE: BE 0462.302.196 subsidiary of

Lifetime

20 annual accounts with figures on one time axis, 28 filings since 1998
peak of €367,539 in 2024
€332,797▼ 9.5%
lowest -€87,333 in 2019
€7,738▲ 56.1%
peak of €101,479 in 2016
-€10,937▲ €7,738
€880,715▼ 9.5%
peak of 4.2 FTE in 2024
3.6 FTE▼ 14.3%
Board3 names since 2009
1 director
Owners
100%
Documentsfilings and deeds
29-07-20262 days before the deadline
2025abbreviated format
Result from €4,958 to €7,738Staff from 4.2 FTE to 3.6 FTEEquity from -€18,675 to -€10,937

Key points

from the 2025 annual accounts

Equity

-€10,937
202020212022202320242025

Debts exceed assets in financial year 2025.

Debts

€880,715 101% of the balance sheet
Financial debts 15%Suppliers 28%Taxes and wages 5%Other 52%

Position in the sector

-€10,937

Less equity than 90% of companies in retail trade. The sector median is €314,797, over 13,292 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 1,454 companies had the same profile as APOTHEEK MOENS MORTSEL has now. Each dot stands for 4 companies, two years later.

92.2%
were still trading
4.9%
stopped another way
2.5%
went bankrupt
  • Micro
  • 20 years or older
  • negative equity
  • a profit under 5% of the balance sheet

Another 0.5% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,454 companies, not a prediction for APOTHEEK MOENS MORTSEL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director,
  • 100%score equity €1.6m (2025) · annual accounts 2025 of
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0462302196
1 director appointed, 2 resignations and resign · appointed as sole director · acts as permanent representative · Gazette deed
Registered office moved within Mortsel The registered office moved from Antwerpsestraat 13, 2640 Mortsel to Antwerpsestraat 7, 2640 Mortsel · (director) and (director) reappointed · acts as permanent representative · Board meeting of 31-01-2018 · Gazette deed
2 directors reappointed and (managing director) · acts as permanent representative · General meeting of 09-06-2009 · Gazette deed
All 40 events

Comparable companies

same main activity, similar in size and age
Company
APOTHEEK MOENS MORTSEL Mortsel €0.9m €332,797 -1.3% 3.6
APOTHEEK BROECHOVEN Ternat €0.9m €308,757 55.4% 3.6
Apotheek Kalmthout Veraart Kalmthout €0.8m €354,294 45.4% 4.4
APOTHEEK BOECKMANS Olen €0.9m €308,209 29.6% 3
MELON-WISLEZ Waimes €0.9m €355,237 73.5% 4
PHARMACIE WILQUIN La Louvière €1.0m €336,575 68.8% 3.3
APOTHEEK DRONGEN Ghent €1.0m €301,663 -18.6% 3.7

These companies have the same main activity as APOTHEEK MOENS MORTSEL: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €780,000 and €1m, founded between 1994 and 2002.

Official details

Source: KBO
Status
Active since 30-12-1997Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.086.981.9222640 Mortsel, since 03-06-1998
Financial year end
31 December
Peppol
Reachable since 15-04-2025
Company details

Annual accounts 2025

≈ €1.1mestimated
€869,778▼ 8.8%
Employeeson 31-12-2025
5▲ 25.0%
Filing
Filed on 29-07-2026, 2 days before the end of the filing period
Financials

Insights on APOTHEEK MOENS MORTSEL

APOTHEEK MOENS MORTSEL files the abbreviated format. That format states no turnover. The gross margin rose from €158,247 in 2006 to €332,797 in 2025.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about APOTHEEK MOENS MORTSEL

What is the company number of APOTHEEK MOENS MORTSEL?
The company number of APOTHEEK MOENS MORTSEL is 0462.302.196. The VAT number is the same number with BE in front: BE 0462.302.196.
Where is APOTHEEK MOENS MORTSEL based?
The registered office is at Antwerpsestraat 7, 2640 Mortsel.Company details
What does APOTHEEK MOENS MORTSEL do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK MOENS MORTSEL?
APOTHEEK MOENS MORTSEL is a public limited company (NV).
When was APOTHEEK MOENS MORTSEL founded?
APOTHEEK MOENS MORTSEL was founded on 30-12-1997.
Is APOTHEEK MOENS MORTSEL still active?
Yes, APOTHEEK MOENS MORTSEL is an active enterprise in the KBO register.
How many employees does APOTHEEK MOENS MORTSEL have?
APOTHEEK MOENS MORTSEL had an average of 3.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK MOENS MORTSEL?
The turnover in financial year 2025 is about €1.1m. This figure is estimated from the gross margin of €332,797 and 42 comparable companies (NACE 477). It probably lies between €900,000 and €1.6m.
Is APOTHEEK MOENS MORTSEL profitable?
In financial year 2025, APOTHEEK MOENS MORTSEL made a profit of €7,738.
Where can I find the annual accounts of APOTHEEK MOENS MORTSEL?
APOTHEEK MOENS MORTSEL filed 28 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK MOENS MORTSEL due?
APOTHEEK MOENS MORTSEL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.